CA9 and neoplasm: Therefore, treatment with the commonly used FOLFOX or FOLFIRI regimens in combination with SLC-0111 is entirely viable and showed a significant decrease in spheroid viability in our combination treatment trials and might, therefore, be an option for chemotherapeutic treatment of CRC if expression of CAIX and CAXII is high in the patient’s tumor.